Clinical Trials Browser

Phase 3 × Interventional × BI 6727 × Clear all

NCT01721876 2023-02-08

Volasertib in Combination With Low-dose Cytarabine in Patients Aged 65 Years and Above With Previously Untreated Acute Myeloid Leukaemia, Who Are Ineligible for Intensive Remission Induction Therapy (POLO-AML-2)

Phase 3 Completed

666 enrolled 14 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute